Artificial pancreas tested on 15 patients

An artificial pancreas developed by CEA-Leti and CERTID (a private-sector diabetes research center) was recently tested on 15 patients. The system consists of an insulin pump, a blood-sugar sensor, and a dedicated algorithm installed on a smartphone. The algorithm uses the patient’s profile and activity (meals, physical exercise) to calculate the insulin dosage, which is automatically delivered by the pump.
Clinical testing demonstrated that the artificial pancreas was very effective at maintaining patients’ blood sugar at the right levels. A joint lab between Leti and CERTID is currently being set up to pursue the development work. An initial prototype should be available by the end of 2015.

Contact: pierre.jallon@cea.fr

Facebook

Twitter